中国血管医学的过去、现在和将来

VASCULAR MEDICINE IN CHINA:PAST, PRESENT AND FUTURE

远古有文字记录的血管医学资料可回朔到2000多年以前,当时是以中医、中药和针灸为主要诊治血管疾病的手段。现代医学自18世纪末引入,至上世纪50年代初可进行一些动脉结扎和截肢类的手术。20世纪60年代以后,以我国断肢(指、趾)再植的成功及布加综合征治疗方面的创新标志着我国显微血管外科和血管外科的发展和领先水平。从20世纪90年代初始以微创法成功治疗创伤性动静脉瘘,后又以同法治愈腹主动脉瘤,并于20世纪90年代末开始用以治疗夹层动脉瘤并取得成功。近来细胞和分子水平的研究已经取得一些成果。展望前景,腔内治疗将被广泛地应用,其装置将获进一步改进。基因和药物涂层支架、组织工程技术将在血管外科中得到更广泛而有效地应用。

Objectives: To review and foresee the development of vascular surgery in China. Methods: Four stages, i. e. , ancient, past, present and future are divided to collect material for analysis. Results: Ancient stage can date back to as early as more than 2000 years ago, Chinese traditional medicine using herbs, acupuncture, moxibustion were the main remedies. Past: Western medicine was introduced into China at the end of 18th century. In terms of modern vascular surgery, only arterial ligation for vascular trauma or aneurysms and amputation could be accomplished until early 1950 s. Present: The development of microvascular surgery was promoted by the use of artificial vascular graft and the application of new operation types such as replantation, thromboendarterectomy. The innovative work done for solving the previously awkward and rarely seen Budd-Chiari syndrome (BCS) brings the Chinese vascular surgery to the world level. Endolumi-nal therapy: Stent deployment in the TVC to treat BCS.